Patent Assignment
Reel/Frame 066478/0740
Assignment of Assignor's Interest
Recorded: 2024-02-16
Pages: 3
Assignor
CATALENT PHARMA SOLUTIONS, LLC
Executed: 2021-09-14
Assignee
SAGE THERAPEUTICS, INC.
215 FIRST STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(2)
Formulations of 19-nor C3,3-Disubstituted C21-N-Pyrazolyl Steroid and Methods of Use Thereof
Application:
17/579,541 →
Publication:
US 2023/0057130
Formulations of 19-nor C3,3-Disubstituted C21-N-Pyrazolyl Steroid and Methods of Use Thereof
Application:
18/006,141 →
Publication:
US 2023/0285417
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 16, 2024
From: WATSON, PAUL STEVEN; BERNER, BRET; NARAYAN, PADMA; CHEN, XIAOXIA
To: SAGE THERAPEUTICS, INC.
Reel/Frame 066477/0814 →
Assignment of Assignor's Interest
Feb 16, 2024
From: STUTZMAN, TODD ANTHONY; MENG, JIANING; WILKERSON, CAROLYN S.; JAIN, RAJ RAMNIK
To: CATALENT PHARMA SOLUTIONS, LLC
Reel/Frame 066478/0287 →
Assignment of Assignor's Interest
Jul 24, 2024
From: WATSON, PAUL STEVEN; BERNER, BRET; NARAYAN, PADMA; CHEN, XIAOXIA
To: SAGE THERAPEUTICS, INC.
Reel/Frame 068067/0519 →
Change of Name
May 13, 2026
From: SAGE THERAPEUTICS, INC.
To: SAGE THERAPEUTICS, LLC
Reel/Frame 075610/0448 →